Theralase Technologies Inc. (TLT.V)
CAD 0.27
(0.0%)
CAD 0.27
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.07 Million | 1.13 Million | 780.64 Thousand | 929.12 Thousand | 964.05 Thousand | 1.73 Million |
| Cost of Revenue | 508.17 Thousand | 510.39 Thousand | 470.69 Thousand | 659.44 Thousand | 903.29 Thousand | 786.43 Thousand |
| Gross Profit | 562.13 Thousand | 628.17 Thousand | 309.94 Thousand | 269.68 Thousand | 60.75 Thousand | 947.63 Thousand |
| Operating Expenses | 562.13 Thousand | 5.85 Million | 4.85 Million | 5.96 Million | 7.48 Million | 4.31 Million |
| Selling, General and Administrative Expenses | 2.12 Million | 1.52 Million | 1.84 Million | 2.47 Million | 3.24 Million | 2.56 Million |
| Research and Development Expenses | 2.77 Million | 4.28 Million | 2.92 Million | 3.44 Million | 4.15 Million | 1.7 Million |
| Other Expenses | - | 48.85 Thousand | 77.15 Thousand | 47.75 Thousand | 74.75 Thousand | 42.1 Thousand |
| Cost and Expenses | 5.66 Million | 6.37 Million | 5.32 Million | 6.62 Million | 8.38 Million | 5.1 Million |
| Operating Income | -4.59 Million | -5.2 Million | -4.51 Million | -5.59 Million | -7.38 Million | -3.36 Million |
| Interest Expense | 30.4 Thousand | 21.24 Thousand | 5342.00 | 9680.00 | 12.35 Thousand | 663.00 |
| Income Tax Expense | 1.00 | 13.17 Thousand | 5342.00 | 9680.00 | 12.35 Thousand | 11.02 Thousand |
| Earnings before Tax | -4.57 Million | -5.23 Million | -4.41 Million | -5.59 Million | -7.41 Million | -3.35 Million |
| Net Income | -4.57 Million | -5.24 Million | -4.41 Million | -5.6 Million | -7.42 Million | -3.35 Million |
| Earnings Per Share Basic | -0.02 | -0.03 | -0.02 | -0.03 | -0.05 | -0.03 |
| Earnings Per Share Diluted | -0.02 | -0.03 | -0.02 | -0.03 | -0.05 | -0.03 |
| Weighted Average Shares Outstanding | 219.96 Million | 207.92 Million | 204.27 Million | 204.27 Million | 144.68 Million | 130.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 219.96 Million | 207.92 Million | 204.27 Million | 204.27 Million | 144.68 Million | 130.48 Million |
| Gross Margin | 0.53 | 0.55 | 0.40 | 0.29 | 0.06 | 0.55 |
| EBIT Margin | -3.97 | -4.29 | -5.43 | -5.73 | -7.40 | -1.80 |
| Profit Margin | -4.27 | -4.61 | -5.66 | -6.04 | -7.70 | -1.94 |
| EBITDA | -4.25 Million | -4.9 Million | -4.31 Million | -5.55 Million | -7.14 Million | -3.14 Million |
| Earnings Before Tax Margin | -4.29 | -4.57 | -5.79 | -6.02 | -7.66 | -1.94 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 100.84 Thousand | 175.55 Thousand | 363.61 Thousand | 1.07 Million | 280.6 Thousand | 218.92 Thousand |
| Cost of Revenue | 133.98 Thousand | 175.21 Thousand | 208.85 Thousand | 765.15 Thousand | 138.93 Thousand | 174.63 Thousand |
| Gross Profit | -33.13 Thousand | 344.00 | 154.75 Thousand | 305.15 Thousand | 141.67 Thousand | 44.29 Thousand |
| Operating Expenses | 1.1 Million | 1.46 Million | 1.15 Million | 4.89 Million | 1.15 Million | 1.2 Million |
| Selling, General and Administrative Expenses | 464.11 Thousand | 568.76 Thousand | 511.46 Thousand | - | 493.35 Thousand | 548.51 Thousand |
| Research and Development Expenses | 642.74 Thousand | 893.09 Thousand | 644.18 Thousand | - | 665.55 Thousand | 656.8 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.24 Million | 1.63 Million | 1.36 Million | 5.66 Million | 1.29 Million | 1.37 Million |
| Operating Income | -1.13 Million | -1.46 Million | -1 Million | -4.59 Million | -1 Million | -1.16 Million |
| Interest Expense | 6240.00 | 6639.00 | 7031.00 | 30.4 Thousand | 7415.00 | 7794.00 |
| Income Tax Expense | 4.00 | -188.2 Thousand | 3.00 | -4.00 | -64.44 Thousand | 1.00 |
| Earnings before Tax | -1.13 Million | -1.45 Million | -991.02 Thousand | -4.57 Million | -1.01 Million | -1.15 Million |
| Net Income | -1.13 Million | -1.26 Million | -991.02 Thousand | -4.57 Million | -1.01 Million | -1.15 Million |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.00 | - | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.00 | - | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 231.89 Million | 229.46 Million | 228.46 Million | 219.96 Million | 217.82 Million | 216.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 231.89 Million | 229.46 Million | 228.46 Million | 219.96 Million | 217.82 Million | 216.5 Million |
| Gross Margin | -0.33 | 0.00 | 0.43 | 0.29 | 0.50 | 0.20 |
| EBIT Margin | -10.64 | -7.94 | -2.56 | - | -3.58 | -4.98 |
| Profit Margin | -11.24 | -7.22 | -2.73 | -4.27 | -3.62 | -5.28 |
| EBITDA | -1.07 Million | -1.39 Million | -929.12 Thousand | - | -1 Million | -1.08 Million |
| Earnings Before Tax Margin | -11.30 | -8.33 | -2.75 | -4.29 | -3.58 | -5.30 |
QRTEB
NC
600272
BM8
AQNB
PH2